Literature DB >> 8129042

Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease.

B T Hyman1, T E Elvhage, J Reiter.   

Abstract

MAP kinases (MAPK) are a family of serine/threonine (Ser/Thr) kinases that link cell surface signals to changes in enzyme activity and gene expression. They are the products of the newly described gene family referred to as extracellular signal regulated kinases (ERKs). Moreover, MAPKs phosphorylate tau in vitro at Ser/Thr Proline sites, generating a multiply phosphorylated tau protein that is similar to the hyperphosphorylated tau found in Alzheimer neurofibrillary tangles (NFTs). We studied MAPK immunoreactivity and in situ hybridization patterns of the two major genes that comprise MAPK activity, ERK1 and ERK2, in the human hippocampal formation. Our goal was to determine whether the pattern of ERK expression is consistent with the hypothesis that MAPKs contribute to NFT formation. ERK1 mRNA is present in small amounts and confined primarily to dentate gyrus granule cells. ERK2 mRNA, by contrast, gives a much stronger hybridization signal and is present in dentate gyrus granule cells and pyramidal cells throughout all hippocampal subfields and adjacent temporal neocortex. Quantitative measures of ERK2 mRNA reveal that NFT-bearing neurons contain approximately 15% less ERK2 mRNA than nearest neighbors that do not contain NFT. NFT-bearing neurons contain approximately 25% less polyA mRNA, suggesting a relative preservation of ERK2 mRNA even in metabolically compromised cells. MAPK immunoreactivity (which represents both ERK1 and ERK2) is seen in neuronal soma, dendrites, axons, and in reactive astrocytes. In Alzheimer's disease, neurons that contain NFTs are also MAPK immunoreactive, but neurons that contain the highest amounts of MAPK immunoreactivity are not necessarily vulnerable for NFT. MAPK immunoreactivity is present in the same neurons as NFT and in the same subcellular compartments as tau, supporting a role for MAPKs in tau phosphorylation in Alzheimer's disease. However, the presence of ERK immunoreactivity is not sufficient to predispose neurons to NFT formation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8129042      PMCID: PMC1887090     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  Memory-related neural systems in Alzheimer's disease: an anatomic study.

Authors:  B T Hyman; G W Van Hoesen; A R Damasio
Journal:  Neurology       Date:  1990-11       Impact factor: 9.910

2.  Electroconvulsive treatment induces a rapid and transient increase in tyrosine phosphorylation of a 40-kilodalton protein associated with microtubule-associated protein 2 kinase activity.

Authors:  K R Stratton; P F Worley; J S Litz; S J Parsons; R L Huganir; J M Baraban
Journal:  J Neurochem       Date:  1991-01       Impact factor: 5.372

3.  Evidence that pp42, a major tyrosine kinase target protein, is a mitogen-activated serine/threonine protein kinase.

Authors:  A J Rossomando; D M Payne; M J Weber; T W Sturgill
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

4.  The purification of tau protein and the occurrence of two phosphorylation states of tau in brain.

Authors:  G Lindwall; R D Cole
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

5.  An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control.

Authors:  T G Boulton; G D Yancopoulos; J S Gregory; C Slaughter; C Moomaw; J Hsu; M H Cobb
Journal:  Science       Date:  1990-07-06       Impact factor: 47.728

6.  A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf.

Authors:  C A Lange-Carter; C M Pleiman; A M Gardner; K J Blumer; G L Johnson
Journal:  Science       Date:  1993-04-16       Impact factor: 47.728

7.  Polyadenylated messenger RNA in paired helical filament-immunoreactive neurons in Alzheimer disease.

Authors:  W S Griffin; C Ling; C L White; M Morrison-Bogorad
Journal:  Alzheimer Dis Assoc Disord       Date:  1990       Impact factor: 2.703

8.  Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids.

Authors:  J Baudier; R D Cole
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

9.  Phosphorylation of microtubule-associated protein tau: identification of the site for Ca2(+)-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles.

Authors:  B Steiner; E M Mandelkow; J Biernat; N Gustke; H E Meyer; B Schmidt; G Mieskes; H D Söling; D Drechsel; M W Kirschner; M Goedert; E Mandelkow
Journal:  EMBO J       Date:  1990-11       Impact factor: 11.598

10.  Tau protein becomes long and stiff upon phosphorylation: correlation between paracrystalline structure and degree of phosphorylation.

Authors:  T Hagestedt; B Lichtenberg; H Wille; E M Mandelkow; E Mandelkow
Journal:  J Cell Biol       Date:  1989-10       Impact factor: 10.539

View more
  25 in total

1.  Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinases.

Authors:  Y Luo; J D Bond; V M Ingram
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Behavioral and Cognitive Improvement Induced by Novel Imidazoline I2 Receptor Ligands in Female SAMP8 Mice.

Authors:  Christian Griñán-Ferré; Foteini Vasilopoulou; Sònia Abás; Sergio Rodríguez-Arévalo; Andrea Bagán; Francesc X Sureda; Belén Pérez; Luis F Callado; Jesús A García-Sevilla; M Julia García-Fuster; Carmen Escolano; Mercè Pallàs
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

Review 3.  miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy.

Authors:  Hanuma Kumar Karnati; Manas Kumar Panigrahi; Ravi Kumar Gutti; Nigel H Greig; Ian A Tamargo
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

4.  Aged dominant negative p38α MAPK mice are resistant to age-dependent decline in adult-neurogenesis and context discrimination fear conditioning.

Authors:  IbDanelo Cortez; Dmitry V Bulavin; Ping Wu; Erica L McGrath; Kathryn A Cunningham; Maki Wakamiya; John Papaconstantinou; Kelly T Dineley
Journal:  Behav Brain Res       Date:  2016-10-17       Impact factor: 3.332

5.  Evidence of Abeta- and transgene-dependent defects in ERK-CREB signaling in Alzheimer's models.

Authors:  Qiu-Lan Ma; Marni E Harris-White; Oliver J Ubeda; Mychica Simmons; Walter Beech; Giselle P Lim; Bruce Teter; Sally A Frautschy; Greg M Cole
Journal:  J Neurochem       Date:  2007-08-30       Impact factor: 5.372

Review 6.  The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.

Authors:  Eugenio Barone; Fabio Di Domenico; Cesare Mancuso; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2013-10-02       Impact factor: 5.996

Review 7.  Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism.

Authors:  D Allan Butterfield; Miranda L Bader Lange
Journal:  J Neurochem       Date:  2009-09-23       Impact factor: 5.372

8.  Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation.

Authors:  S M Greenberg; E H Koo; D J Selkoe; W Q Qiu; K S Kosik
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

9.  In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms.

Authors:  J W Mandell; I M Hussaini; M Zecevic; M J Weber; S R VandenBerg
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

10.  Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model.

Authors:  Shreyasi Chatterjee; Tzu-Kang Sang; George M Lawless; George R Jackson
Journal:  Hum Mol Genet       Date:  2008-10-17       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.